Medical Device Reimbursement Strategies:Get Your Product to Market at the Right Price
Product Details
“Reimbursement is the biggest fear in start-ups and venture capital right now. Our clinical and technical results exceed any expectation ... and the only thing people say is, ‘What is the reimbursement strategy?’”
— CEO of a start-up device company
Register you and your team now and save!
Your medical device has it all … the latest technology ... life-changing benefits. But let’s face it: “reasonable and necessary” reimbursements won’t reward your hard work with profits.
It’s imperative to be more aggressive in developing robust reimbursement plans and consider evidence development much earlier in the planning cycle.
This is the only workshop that gives you two days of face-to-face access to 20-year industry veteran Randel Richner, an expert in comparative effectiveness and a veteran of Boston Scientific and GlaxoSmithKline, and her real-world medical device reimbursement strategies. She’ll be joined by Dr. Peter Neumann, a world-renown health outcomes and technology assessment leader.
And this is the one workshop that delivers — even with changes coming from the Obama administration — proven reimbursement tips and tactics, including:
- Most common mistakes companies make in applying for new codes and payment rates (and how to avoid them!)
- Ways the new Medicare reorganization will affect your coverage
- Why marketing can help (or hurt) your chance of reimbursement success
- How value-based purchasing and quality reporting impact your device sales
- The role you should be playing in health technology assessments
These reimbursement strategies are already winning advances for medical device manufacturers across the U.S., Europe and Asia ... and now you can put these profit-building methods to work for your medical device too!
Register now and discover:
- What evidence-based medicine, comparative effectiveness and value-based purchasing are, and how it affects medical technology
- Who creates the evidence and how a manufacturer can manage development costs and efficiencies to accommodate new evidence requirements
- How data can be leveraged on a global basis
- How your regulatory, clinical and marketing efforts impact the value story and reimbursement success
- How to avoid delays in FDA approval or complicating the FDA process with additional need for economic and reimbursement information
- How the new Medicare administrative contractor reorganization will affect coverage
- How you can determine if you need to seek a Medicare or private insurer coverage decision for your device or diagnostic
- What a health technology assessment is and what role will you play
- How to work with medical societies
- What the best strategies are for communicating with payer medical directors and what approaches should you avoid
- Exactly what value-based purchasing, pay-for-performance and quality reporting are, and how they impact medical product sales
- What the most common mistakes are when applying for a new code or new payment rate, and how they can be avoided
Put Ask-a-Payer-Medical Director, Gary Owens, M.D., to Work for You
At each workshop, the medical director of a MAJOR payer will be on-site and ready to answer your toughest questions:
- “What are my best strategies for communicating with payer medical directors?”
- “What should I avoid?”
- “How do payer medical directors make coverage decisions?”
- Plus inside answers to all your mission-critical questions
Remember: It only takes a “YES” from a handful of payers to get your device covered ... and achieve your revenue goals.
It’s the best chance to build your payer network in 2009 — register now!
Gary Owens, M.D. is currently president of Gary Owens Associates. In this role, he provides consulting services to pharmaceutical companies, device manufacturers, benefits consultants and managed care plans. Dr. Owens has expertise in the evaluation of new technology, medical management programs and strategy, health plan operations, benefit design, formulary development and drug management.
Dr. Owens brings more than 20 years of experience in medical and pharmacy management to his clients. Previously he managed multiple operations in a large regional health plan and was directly responsible for the implementation of numerous strategic initiatives that included the 2006 launch of FutureScripts, a wholly owned PBM of Independence Blue Cross.
Dr. Owens was vice president for medical management and policy at independence Blue Cross from 2003 to 2006. In that role, he managed pharmacy operations for more than two million members and was a leader in the evaluation and management of biotech drugs at the health plan. From 1996 to 2003, Dr. Owens was vice president for patient care management, where he was responsible for medical management services for more than three million members and nearly seven billion dollars of annual medical spending activity. From 1986 to 1996, Dr. Owens had multiple duties as a senior medical director and medical director at Independence Blue Cross and the affiliates Keystone Health Plan East and Delaware Valley HMO.